Algorhythm Holdings, Inc. (RIME) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Algorhythm Holdings, Inc. on December 17, 2024, with the earliest event reported on the same date. The Company, incorporated in Delaware and trading on the Nasdaq Capital Market under the symbol "RIME," reported the entry into a material definitive agreement regarding a registered direct offering of common stock.
Key Financial Metrics and Transaction Details
- Transaction Type: Registered Direct Offering of Common Stock.
- Shares Issued: 24,067,388 shares.
- Purchase Price: $0.0831 per share.
- Gross Proceeds: Approximately $2.0 million (calculated as 24,067,388 shares x $0.0831).
- Net Proceeds: Approximately $1.6 million after deducting estimated offering expenses and placement agent fees.
- Placement Agent Fee: 8% of aggregate gross proceeds paid to Univest Securities, LLC.
- Use of Proceeds: Working capital and general corporate purposes.
- Closing Date: December 18, 2024.
The filing does not provide specific data on revenue, profit, cash flow, margins, or existing debt levels as this report focuses solely on the capital raise event.
Material Changes
The primary material change is the dilution of existing shareholders due to the issuance of approximately 24.1 million new shares. The Company's cash position is expected to increase by approximately $1.6 million upon the closing of the transaction.
Outlook, Risks, and Management Commentary
Management intends to utilize the net proceeds to fund working capital and general corporate needs. The offering was conducted pursuant to a Registration Statement on Form S-3 (File No. 333-269183) declared effective in January 2023. No specific forward-looking guidance regarding future revenue or earnings was included in this filing. The filing notes that summaries of the agreements are subject to the full text of the attached exhibits.
Key Facts for Investor Verification
- Verify the exact number of shares outstanding post-offering to assess the degree of dilution.
- Confirm the final net proceeds received after all transaction costs are settled.
- Review the full Securities Purchase Agreement (Exhibit 10.1) for any registration rights or anti-dilution provisions granted to the new investors.
- Monitor the Company's cash burn rate to determine how long the $1.6 million in new capital will sustain operations.